Date: Mar 12, 2019 Source: Mass Device (
click here to go to the source)
Exactech (NSDQ:EXAC) said today that it acquired knee replacement surgery instrument maker XpandOrtho for an undisclosed amount.
Gainesville, Fla.-based Exactech said that it plans to incorporate XpandOrtho's soft tissue balancing technology into its ExactechGPS computer-assisted surgery system designed to support shoulder and knee replacements.
"This allows our technology, which has been in development for more than seven years, to be brought to market for the benefit of surgeons and their patients," founder Dr. Clifford Colwell said in a prepared statement.
XpandOrtho won FDA clearance in 2017 for an electronic soft-tissue balancing instrument intended for total knee arthroplasty. The tool uses multiple sensors within a knee joint to guide soft tissue balancing, and a novel pneumatic-based bellows system which wirelessly communicates with a display to provide gap balancing feedback throughout the knee's range of motion, the companies said.
"The acquisition of XpandOrtho supports Exactech's growth strategy and commitment to improving surgeon experience and patient outcomes. Their innovative ligament balancing technology provides a strong framework for integration into our ExactechGPS system to further advance our award-winning Truliant total knee system. We look forward to collaborating with XpandOrtho founders Cliff Colwell and Darryl D'Lima on continued development of advanced knee replacement technology," Exactech CEO David Petty said in a press release.
Last March, Exactech said that it won FDA clearance for its Equinoxe stemless shoulder prosthesis designed to be compatible for use with the Equinoxe shoulder system.